首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis systemic lupus erythematosus rheumatoid arthritis and mixed connective tissue disease.
【2h】

Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis systemic lupus erythematosus rheumatoid arthritis and mixed connective tissue disease.

机译:系统性硬化症系统性红斑狼疮类风湿性关节炎和混合性结缔组织病患者的外周血白细胞产生白细胞内源性介体(白介素1)的缺陷。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Leucocytic endogenous mediator is one of the activities ascribed to the cytokine or family of cytokines known as interleukin 1. In this study we have examined the ability of circulating blood leucocytes from patients with rheumatic diseases to produce this mediator in vitro. Leucocytic endogenous mediator production was found to be significantly decreased below normal values (mean 107 units, s.e.m. +/- 25) in systemic sclerosis (-6 units +/- 18), systemic lupus erythematosus (-25 units +/- 13), rheumatoid arthritis (-3 units +/- 13) and mixed connective tissue disease (-4 units +/- 40). A control group of ill patients with cancer produced 57 units +/- 8.
机译:白细胞内源性介体是归因于细胞因子或称为白介素1的细胞因子家族的活动之一。在这项研究中,我们研究了风湿性疾病患者循环血液白细胞在体外产生这种介体的能力。发现系统性硬化症(-6个单位+/- 18),系统性红斑狼疮(-25个单位+/- 13)的白细胞内源性介体产量显着低于正常值(平均107个单位,sem +/- 25),类风湿关节炎(-3单位+/- 13)和混合性结缔组织病(-4单位+/- 40)。对照组患病的癌症患者产生57个单位+/- 8。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号